For the Inventor, By the Inventor

Enter assignee name

Faron Pharmaceuticals Oy

USPTO Granted Patents = 16

CIPO Patents = 2

EPO Patents = 15

Trademarks = 1

Forward Citations = 12

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Markku Jalkanen (9 out of 16 patents)

Sirpa Jalkanen (8 out of 14 patents)

Mikael Maksimow (6 out of 6 patents)

4. Marko Salmi (6 out of 11 patents)

5. Marita Vainio (3 out of 3 patents)

6. Juho Jalkanen (3 out of 3 patents)

7. Heikki Irjala (2 out of 2 patents)

8. Matti Karvonen (2 out of 6 patents)

9. Jami Mandelin (2 out of 2 patents)

10. Maija-Leena Hollmén (1 out of 1 patent)

11. Miro Viitala (1 out of 1 patent)

12. Ilse Piippo (1 out of 1 patent)

13. Alexander Spicer (1 out of 1 patent)

14. Reetta Virtakoivu (0 patent)

15. Felix Vaura (0 patent)

16 patents: Sort by Forward Citations

1. 12662533 - STABLE ANTI-CLEVER-1 ANTIBODY FORMULATION (2026-06-23),

2. 12553906 - METHOD FOR DETERMINING POTENCY OF THERAPEUTIC ANTI-CLEVER-1 ANTIBODY (2026-02-17),

3. 12472235 - Treatment of diseases with sequential administration of an agent capable of up-regulating CD73 and glucocorticoids (2025-11-18),

4. 12371486 - Humanized anti clever-1 antibodies and their use (2025-07-29),

5. 11421279 - Method for determining patient's responsiveness to type 1 interferon treatment and use of type 1 interferon to treat patient having specified single nucleoide polymophism (2022-08-23),

6. 11046761 - Humanized anti clever-1 antibodies and their use (2021-06-29),

7. 10884000 - Method of monitoring the efficacy of the anti-clever-1 therapy in cancer (2021-01-05),

8. 10526607 - Cell and therapeutical and diagnostical methods based thereon (2020-01-07),

9. 10293030 - Lyophilised pharmaceutical formulation and its use (2019-05-21),

10. 10247730 - Method for determining acute respiratory distress syndrome (ARDS) related biomarkers, a method to monitor the development and treatment of ARDS in a patient (2019-04-02),

11. 8975081 - Biomarker for monitoring development of diseases and assessing the efficacy of therapies (2015-03-10),

12. 8722045 - Cell and therapeutical and diagnostical methods based thereon (2014-05-13),

13. 7910097 - Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof (2011-03-22),

14. 7727521 - Method of ameliorating multi-organ failure resulting from ischemic reperfusion injury (2010-06-01),

15. 7534423 - Method for inducing an elevated level of adenosine in an individual (2009-05-19),

Company Overview

Faron Pharmaceuticals Oy is a biopharmaceutical company based in Turku, Finland, specializing in the development of innovative therapies for cancer and other serious diseases. The company focuses on advancing its proprietary drug candidates through clinical trials, leveraging cutting-edge research in immunotherapy and targeted treatments. Faron's commitment to scientific excellence and patient-centric solutions positions it as a key player in the global biopharmaceutical landscape, aiming to address unmet medical needs with its novel therapeutic approaches.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

16 Patents

#9 in Turku

#201 in Finland

#37,788 in the World

Faron Pharmaceuticals Oy

Forward Citations = 12

13 inventors:

Markku Jalkanen (9 out of 16 patents)

Sirpa Jalkanen (8 out of 14 patents)

Mikael Maksimow (6 out of 6 patents)

4. Marko Salmi (6 out of 11 patents)

5. Marita Vainio (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Faron Pharmaceuticals Oy. Retrieved from https://idiyas.com/company/faron-pharmaceuticals-oy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…